Emanuele Ostuni
Algemeen Directeur bij Artbio AS
Oorsprong van het eerstegraads netwerk van Emanuele Ostuni
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021.
2
| Holding Company | Hospital/Nursing Management | 2 |
Artbio AS
Artbio AS BiotechnologyHealth Technology Part of Artbio, Inc., Artbio AS is a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines. The company is based in Oslo, Norway. The Norwegian company was founded in 2018. The CEO is Emanuele Ostuni.
1
| Subsidiary | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emanuele Ostuni via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
PHOTOCURE ASA | Medical Specialties | Director/Board Member | |
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway. | Financial Conglomerates | Chief Investment Officer | |
University of Oslo | College/University | Doctorate Degree Corporate Officer/Principal | |
BI Norwegian Business School | College/University | Graduate Degree | |
Ernst & Young AS
Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Founder Founder | |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
Nucligen AS | Director/Board Member | ||
Radforsk | Chief Investment Officer | ||
Sciencons AS
Sciencons AS Financial ConglomeratesFinance Sciencons AS is an investment company that focuses on research and development businesses. The company was founded on January 2, 2014 and is headquartered in Oslo, Norway. | Financial Conglomerates | Chief Executive Officer |
Statistieken
Internationaal
Noorwegen | 17 |
Verenigde Staten | 2 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 7 |
Commercial Services | 4 |
Consumer Services | 4 |
Finance | 3 |
Miscellaneous | 2 |
Operationeel
Director/Board Member | 9 |
Founder | 9 |
Chairman | 7 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Sterkste connecties
Insiders | |
---|---|
Anders Tuv | 12 |
Roy Hartvig Larsen | 9 |
Øyvind Sverre Bruland | 5 |
- Beurs
- Insiders
- Emanuele Ostuni
- Bedrijfsconnecties